Archive for September, 2019

$CNPOF Clinches Deal to Grow 17,000 Acres of Hemp in China

September 30, 2019

A Toronto-based cannabis company announced on Tuesday that it had signed an agreement with a Chinese partner allowing the Canadian company to grow and process industrial hemp on 17,000 acres in China.

Pure Global Cannabis, the Canadian company, signed this agreement with a Chinese company called KMT-Hansa Corp. KMT currently holds licenses to grow and process hemp on 17,000 acres in China, and they are teaming up with Pure Global to pull it off.

Under the terms of the agreement, Pure Global will be responsible for providing the technology, know-how and the plant genetics required for the success of the project. Pure Global will also take charge of distribution and sales of all the products that are made during the execution of the joint project.

The Canadian company has also been tasked with designing the extraction, processing and manufacturing facilities that comply with Good Manufacturing Practices (GMP).

Another seller or distributor for the products made can only be sourced once Pure Global declares that it is waiving its right to this component of the business.

KMT-Hansa Corp. will take charge of making sure that all the necessary licenses and permits are secured and maintained with all the relevant Chinese government authorities.

Malay Panchal, the President and CEO of Pure Global, revealed in a press statement that he was excited that Pure Global had managed to be the first Canadian company to secure a partnership that enabled it to put together such a large-scale project in China.

Panchal believes that the entire team at KMT shares Pure Global’s goal of coming up with high-quality agricultural products that are made using the best cutting-edge technology currently available.

This agreement is viewed by both parties as a stepping stone to other bigger international production agreements between the two entities. The two companies are therefore committed to moving quickly to address the needs of a rapidly growing market for CBD products.

Pure Global and KMT plan to sell CBD isolates and consumer products throughout Asia as well as 50 international markets where CBD is legal.

Panchal also revealed that this is an exciting time for Pure Global because they have not only managed to secure the deal with KMT, but have also received a cannabis oils sales license from Health Canada.

Experts believe that partnerships such as those entered into by Pure Global Cannabis and KMT-Hansa Corp. provide impetus to other hemp companies, such as Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) and Earth Science Tech Inc. (OTCQB: ETST), to work harder and increase their international footprint in order to tap the global market for hemp-derived products.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

Monday, September 30th, 2019 Uncategorized Comments Off on $CNPOF Clinches Deal to Grow 17,000 Acres of Hemp in China

$POAI Repayment or Extension of Promissory Notes

MINNEAPOLIS, Sept. 30, 2019 — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced that its secured promissory notes that were due September 28, 2019 have been repaid or extended. On September 27, 2019, the Company repaid the remaining principal and interest balance of $478,590 on one of such notes. On the same date, the Company obtained a new investment of $700,000 from a private investor in exchange for a new 8% secured promissory note due on March 27, 2020 with an original principal amount of $847,500. The Company also issued 88,574 shares of common stock and a 682,368 share warrant to the new investor.

In addition, on September 27, 2019, the Company amended the other outstanding note to extend the maturity date from September 28, 2019 to December 31, 2019. The outstanding principal amount of the note was increased by $120,000 to a current principal amount of $1,789,104, and the Company issued 150,000 shares of common stock to the investor in connection with certain amended terms.

About Predictive Oncology Inc.

Predictive Oncology Inc. (NASDAQ: POAI) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for patients and clinicians as well as clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal.

Forward-Looking Statements

Certain of the matters discussed in the press release contain forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include (i) risks related to the recent merger with Helomics, including the fact that the combined company will not be able to continue operating without additional financing; possible failure to realize anticipated benefits of the merger; costs associated with the merger may be higher than expected; the merger may result in disruption of the Company’s and Helomics’ existing businesses, distraction of management and diversion of resources; and the market price of the Company’s common stock may decline as a result of the merger; (ii) risks related to our partnerships with other companies, including the need to negotiate the definitive agreements; possible failure to realize anticipated benefits of these partnerships; and costs of providing funding to our partner companies, which may never be repaid or provide anticipated returns; and (iii) other risks and uncertainties relating to the Company that include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; sales cycles that can be longer than expected, resulting in delays in projected sales or failure to make such sales; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; Predictive Oncology’s ability to implement its long range business plan for various applications of its technology; Predictive Oncology’s ability to enter into agreements with any necessary marketing and/or distribution partners and with any strategic or joint venture partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of Predictive Oncology’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the SEC, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of Predictive Oncology’s financial position. See Predictive Oncology’s most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.

Contact
Bob Myers, Predictive Oncology Inc.
651-389-4800

Monday, September 30th, 2019 Uncategorized Comments Off on $POAI Repayment or Extension of Promissory Notes

$YGYI Pennsylvania Governor Support for Recreational Marijuana Legalization

September 30, 2019

In a press conference on Wednesday, Tom Wolf, Pennsylvania Governor accompanied by Lt. Gov. John Fetterman, announced his support for the legalization of adult-use recreational marijuana. In his announcement, he included the final report from Lt. Governor John Fetterman’s statewide tour on recreational marijuana legalization. He also proposed the next steps to be taken after reviewing the input submitted by the citizens from the 67 counties who attended their listening sessions or reverted via their online platform.

In his announcement, Governor Wolf said that Lt.Governor Fetterman fulfilled his promise of touring all the 67 counties in Pennsylvania to get the opinion of the citizens regarding the legalization of adult-use recreational marijuana. Moreover, the majority of the feedback received was in favor of recreational marijuana legalization.

Lt. Governor John Fetterman invited the public, media companies and local officials to the tour stops in each county, where the attendees indicated their interest in the bill by a show of hands.

The report comprises of two parts. The first part looks at the volume of messages sent to the online platform hosted on the governor’s website, the comments made on the platform and comment cards collected at the tour stops, as well as any additional message received by the Lt. Gov Fetterman in other formats.

During the announcement, the Lt. Governor voiced his appreciation for the Pennsylvania citizens who attended his tours and those who submitted their comments either physically or online. He also assured the Pennsylvanians that they will do their best to bring into effect the proposed changes.

Apart from announcing the report, the Pennsylvania Governor and Lt. Governor called for the legislature to get a bill that decriminalizes non-violent and cannabis-related offenses to the governor’s desk. They also announced that they are seeking justice by expunging non-violent and small cannabis-related crimes convicted in the past. Finally, they are asking the General Assembly to debate and pass the bill legalizing recreational marijuana.

Since the majority of Pennsylvania residents are in favor of recreational marijuana legalization, Governor Wolf says that he is looking forward to accomplishing many missions together. This includes the criminal justice reform that he is proposing as it will positively affect the people of Pennsylvania.

In his final remarks, Governor Wolf expressed his gratitude to Lt. Gov. John Fetterman for touring the 67 counties and conducting the research. More gratitude was directed towards the Pennsylvanians who attended the tour stops, wrote messages or called the headquarters to voice their opinion.

Analysts are of the view that industry players like Youngevity International Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) will only be happy for the people of Pennsylvania once a legalization bill is passed and signed off.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Monday, September 30th, 2019 Uncategorized Comments Off on $YGYI Pennsylvania Governor Support for Recreational Marijuana Legalization

$TGODF Advances Within Competitive Canadian Cannabis Space

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified-organic cannabis, is on a mission to meet the growing demand for organic cannabis in Canada. An article discussing the company reads, “Recently, TGOD received a 100% organic rating from Toronto-based Corporate Knights magazine (http://cnw.fm/9jgNC). The company is one of the few in Canada licensed to cultivate organic cannabis. The Green Organic Dutchman is a pioneer in shifting from indoor farming to greenhouse cultivation, making use of solar energy and cutting electricity costs by up to 90%. Companies leading this effort are using glass-roofed greenhouses equipped with the latest high-tech equipment to produce ‘sun-grown’ organic cannabis (http://cnw.fm/MP6Ug).”

To view the full article, visit http://cnw.fm/n0hF3

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium, global, organic-cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic-hemp, CBD-oil operations in Canada and, through its wholly owned subsidiary HemPoland, distributes premium-hemp CBD oil in the EU. The company grows high-quality, certified-organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGODF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Friday, September 27th, 2019 Uncategorized Comments Off on $TGODF Advances Within Competitive Canadian Cannabis Space

$OGI Comparing Leading Cannabis Stocks in a Stockpicker’s World

The cannabis space is targeting some relatively remarkable growth estimates, with analysts routinely jacking up forecasts. But two dynamics have made it increasingly difficult for investors in the space: the increasing supply along with demand to suit the process of legislative and mainstream adoption has pressured cannabis pricing, and the enthusiasm of investors along the way has created some valuation issues that have led to significant pain for poorly timed entries.

That leaves us with a classic stockpicker’s market in the pot stock space. We review several candidates to aid in your analysis: Tilray Inc (NASDAQ:TLRY), Medicine Man Technologies Inc (OTCMKTS:MDCL), and OrganiGram Holdings Inc (NASDAQ:OGI).

Tilray Inc (NASDAQ:TLRY) has been a controversial name because the short-squeeze was so dramatic in the opening months of the stock’s listed trading, and yet it has now fallen in such a shocking manner, with the stock’s current woes being directly related to massive debt servicing costs from convertibles – a worse situation one cannot imagine for a company at this stage.

According to company materials, the company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.

Even after the disastrous earnings report, management was typically in denial.

“We are pleased with our second quarter results and strong business momentum,” said Brendan Kennedy, Tilray President and Chief Executive Officer. “Our team has executed against our plan, with adult-use revenue nearly doubling in the second quarter compared to the first quarter and gross margin increasing sequentially for the second quarter in a row. As we continue to grow, we remain focused on our long-term strategic objectives and deploying capital to maximize stockholder value.”

The trading tape continues to be characterized by a pretty dominant offer, which hasn’t been the type of action TLRY shareholders really want to see. In total, over the past five days, shares of the stock have dropped by roughly -11% on above average trading volume. All in all, not a particularly friendly tape, but one that may ultimately present some new opportunities.

Tilray Inc (NASDAQ:TLRY) managed to rope in revenues totaling $45.9M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 371.1%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($220.9M against $175.9M).

But, in all of this, losses continue to pile up much faster than anticipated and the convertible debt servicing undermines that sense of a superficially strong balance sheet.

 

Medicine Man Technologies Inc (OTCMKTS:MDCL) generated sales of $1.8M, according to information released in the company’s most recent quarterly financial report. In addition, the company is sitting on about $4.3M in cash. That puts the stock in a sweet spot as far as valuation in the pot space, with shares trading at around 14x sales.

That sense has fueled aggressive interest in the name, with shares rallying as much as 30% higher so far during September alone.

As we have noted in the past, the company is capitalizing on recent changes in Colorado state law (namely, passage of HB 19-1090, which will take effect on November 1, and allow for outside investors, venture capitalists and private equity firms to gain investment access to Colorado’s cannabis industry.

MDCL has been a well-respected and successful advisor and consultant to firms in the cannabis industry for many years. But this shift in the legal context has created a new opportunity to consolidate production and distribution under the MDCL umbrella in a roll-up that could produce significant revenue growth for a stock that is already cheap relative to peers in the space.

Here’s the company’s CEO on the new bill: “At a time when cannabis is valued at $1.5 billion and is expected to grow to $2.1 billion by 2022 in Colorado alone, this legislation will serve to accelerate Colorado’s leadership position in the entire cannabis industry, and those entities fortunate enough to do business in our state – including our own. This was a tremendous win for the industry and for Medicine Man Technologies.”

In all, the company has entered into binding term sheet agreements to roll up some bread and butter in the Colorado cannabis marketplace, including 12 cultivation facilities, 7 proprietary extraction facilities, 7 manufacturers of infused products, 33 strategically located retail dispensaries, and a state-of-the-art manufacturing, research and development lab that represents Colorado’s first and only active cannabis research license in the state.

 

OrganiGram Holdings Inc (NASDAQ:OGI) recently announced that it has received Health Canada’s approval for the licensing of 17 additional cultivation rooms under the Cannabis Regulations.

According to the release, the new cultivation rooms represent approximately 15,000 kg/yr1 of increased target production capacity. These are the first 17 rooms licensed within the Company’s Phase 4B expansion and now brings the Company’s Moncton facility to annualized licensed capacity to a target of 76,000 kg. The licenses are valid until March 27, 2020 and subject to terms and conditions.

“Once again, we are pleased to receive licensing approval consistent with our expectations and the streamlined process we have experienced to date. Our Phase 4 facility expansion remains on schedule to meet growing demand and further contribute to efficiencies of scale,” explains Greg Engel, CEO, Organigram.

OrganiGram Holdings Inc (NASDAQ:OGI) promulgates itself as a company that, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada.

It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Even with that news, the action hasn’t really heated up in the stock, with shares moving net lower over the past week.

OrganiGram Holdings Inc (NASDAQ:OGI) pulled in sales of $24.8M in its last reported quarterly financials, representing top line growth of 564.3%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($87.8M against $25.7M).

Friday, September 27th, 2019 Uncategorized Comments Off on $OGI Comparing Leading Cannabis Stocks in a Stockpicker’s World

$POAI Bringing Precision Medicine Tools to Physicians

Predictive Oncology (NASDAQ: POAI) is assisting clinicians and researchers in improving outcomes for cancer patients via its AI-driven, tumor-profiling platform. A recent article discussing the company reads, “POAI’s technology combines its database of evidence documenting actual drug responses of cancer patients’ tumors with artificial intelligence (AI) to create an invaluable predictive tool for clinicians and researchers. Predictive Oncology’s data offers a valuable, customizable assessment method that can be used by oncologists to determine the best drug for fighting a specific patient’s cancer. This disruptive technology is the first of its kind and is also meeting a critical need in the pharmaceutical, diagnostic and biotech industries to speed up the search for new precision therapies by providing tools to better predict how new drugs work on different cancers (http://nnw.fm/B4htL). . . . POAI’s wholly owned subsidiaries — Helomics and TumorGenesis — are working together to bring these important precision-medicine tools to physicians.”

To view the full article, visit http://nnw.fm/pV2Fc

About Predictive Oncology Inc.

Predictive Oncology (formerly Precision Therapeutics Inc.) operates through its three business units: Helomics, TumorGenesis and Skyline Medical. Helomics applies artificial intelligence to rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision-oncology platform, Helomics offers boutique CRO services that leverage its TruTumor, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform (D-CHIP) to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, September 27th, 2019 Uncategorized Comments Off on $POAI Bringing Precision Medicine Tools to Physicians

$PBIO VIDEO Update w/ Shelly Craft of SNNLive @StockNewsNow

Pressure BioSciences, Inc. (OTCQB: PBIO) is engaged in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, according to the company’s website (click here: www.pressurebiosciences.com). SNNLive caught up with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. at RHK Capital’s 2019 Disruptive Growth Company Showcase in New York City, NY, and they discuss the following topics:

– Overview of Pressure BioSciences, Inc.

– Update since our last interview (click here)

– Focus on CBD Market

– Adoption rate for new product

– Growth drivers for 2019-2020

For more information about Pressure BioSciences, Inc., please visit: www.pressurebiosciences.com

The interview may contain forward looking statements about Pressure BioSciences, Inc. See Pressure BioSciences’ periodic filings with the Securities and Exchange Commission for more complete information.

Please read our full disclosure here.

Friday, September 27th, 2019 Uncategorized Comments Off on $PBIO VIDEO Update w/ Shelly Craft of SNNLive @StockNewsNow

$GGBXF Jann Parish Named to Forbes CMO Next List

COLUMBUS, OH, Sept. 26, 2019 – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or “the Company”) is pleased to announce that Jann Parish, Chief Marketing Officer, has been named to the Forbes CMO Next list. The list is comprised of 50 individuals who are leading the way as disruptive chief marketers.

Through qualitative research tapping into the expertise of industry watchers as well as Forbes‘ editorial industry knowledge, the list features 50 people who have reached the highest-level marketing position within a given company and who are driving brand and business growth.

“I am honored and humbled to receive this recognition,” said Jann Parish, CMO of Green Growth Brands. “I am thrilled to be applying my expertise to the cannabis and CBD industries. At Green Growth Brands, we look at this moment in time as an opportunity to reinvent the way consumers view and interact with products that have very complicated histories. For Forbes to be considering our industry as part of this award speaks to the progress we have already made.”

“Jann has experience growing and redefining some of the most iconic global brands,” said Peter Horvath, CEO of Green Growth Brands. “Her vision and leadership are pivotal to our strategy— creating the new standard of cannabis and CBD consumer experiences. We are thrilled for her and the well-deserved recognition.”

Through Parish’s leadership GGB has opened over 130 Seventh Sense CBD shops across the U.S., grown Seventh Sense’s digital reach, prepared for the October launch of new CBD brand, Green Lily and increased sales and margin figures in its Nevada The+Source dispensary business by double digits.

About Green Growth Brands Inc.
Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The Company also has a licensing agreement with the Greg Norman™ Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S its CBD presence at ShopSeventhSense.com, in malls across the country, at DSW and Abercrombie & Fitch stores—and that’s just the beginning. Learn more about the vision at GreenGrowthBrands.com.

Cautionary Statements:

Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions.  Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018, which is available on the Company’s issuer profile on SEDAR.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release, including, but not limited to, the Company’s ability to execute on its growth strategy, the Company’s vision to become a multi-state operator with retail stores exceeding certain financial thresholds is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Thursday, September 26th, 2019 Uncategorized Comments Off on $GGBXF Jann Parish Named to Forbes CMO Next List

$CNPOF $RIV.V Announces Results of Annual General and Special Meeting of Shareholders

TORONTO, Sept. 26, 2019 – Canopy Rivers Inc. (“Canopy Rivers” or the “Company“) (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the voting results from its annual general and special meeting of shareholders (the “Meeting“) held today.

32,117,069 of the Company’s issued and outstanding subordinated voting shares (each carrying one vote per share) and 36,468,318 of the Company’s issued and outstanding multiple voting shares (each carrying 20 votes per share), representing 86.14% of the votes attached to all outstanding shares of the Company, were represented in person or by proxy at the Meeting.

Shareholders voted in favour of each of the items of business before the Meeting, including the election of each of the director nominees to serve until the Company’s next annual shareholders’ meeting or until his or her successor is duly elected or appointed. The results are set out below:

 

Name of Director
Nominee
Votes cast
FOR
% votes cast
FOR
Votes
WITHHELD
% votes
WITHHELD
Narbe Alexandrian 754,140,044 99.96% 328,582 0.04%
John K. Bell 748,580,962 99.22% 5,887,664 0.78%
Asha Daniere 754,026,441 99.94% 442,185 0.06%
Richard Mavrinac 754,043,067 99.94% 425,559 0.06%
Joseph Mimran 754,155,065 99.96% 313,561 0.04%

 

For detailed voting results on each matter, please refer to the Company’s Report of Voting Results available under the Company’s profile on SEDAR at www.sedar.com.

About Canopy Rivers:
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Thursday, September 26th, 2019 Uncategorized Comments Off on $CNPOF $RIV.V Announces Results of Annual General and Special Meeting of Shareholders

$TGODF UK Experts Want Medical Marijuana Free for All

September 26, 2019

The UK government has legalized the use of medical marijuana; however, accessing it is next to impossible. This has prompted professors, doctors, health experts, and politicians to sign letters petitioning the government to make medical marijuana free to all patients. To access medical marijuana for free, patients have to present a prescription from the NHS (National Health Service), which serves as the United Kingdom’s comprehensive, universal, and free-at-the-point-of-service system of medication.

It is legal to prescribe medical cannabis under particular conditions on the NHS system; however, there exist several restrictions and obstacles that hinder specialists from prescribing medical marijuana treatment to patients. The letter signed by the pharmacists, health experts, and members of parliament appeals to the UK Health Secretary Matt Hancock to lift these restrictions. The Members of Parliament representing the Liberal Democrats and Labour have also signed a letter to the Prime Minister, Boris Johnson, appealing to him to intervene for the patients who are unable to access medical marijuana prescriptions.

Doctors and politicians are ready to change the highly restrictive measures administered by the UK government regarding legal access to medical cannabis. The UK government system governing access to medical marijuana does not give access to those patients who highly need it, thus causing unnecessary deaths and addiction to painkillers which could be avoided by treating the patient with medical cannabis.

In their letter to Mr. Hancock, the health experts argue that the failure of the medical and pharmacy professions to embrace medical cannabis is the leading cause of death from conditions that could be prevented, such as epilepsy.

A recent study by Public  Health England concludes that a quarter of the population, ‘mainly adults’ consume strong painkillers, sleeping aids and antidepressants. The conditions forcing them to take these medications could be effectively and safely treated using medical marijuana.

Health experts in the UK want these restrictions lifted because it would make it easier for the doctors to prescribe medical cannabis for treatment using the NHS system. They want Hancock to scrape off the rule requiring a senior doctor to sign off on a prescription and allow a general specialist to write medical marijuana prescriptions. Besides, they want the laws governing the importation of medical marijuana simplified.

The proposed changes to medical marijuana could improve the lives of many patients because with a prescription from the medical provider; patients can access medical cannabis freely. Lack of access to medical cannabis prescription forces patients to seek the help of private caregivers who are very expensive; forcing the patients to turn to the use of unregulated weed for relief.

For the long term effect of free medical marijuana to be seen, professors, health experts and MPs advocate for the training of doctors on medical cannabis treatment and the process of prescribing. Medical cannabis should be prescribed to patients suffering from chronic pain, epilepsy, cancer, multiple sclerosis, depression and insomnia.

In response to the letter, NICE (National Institute for Health and Care Excellence) is opposed to the use of medical marijuana, citing lack of enough clinical evidence.

Industry analysts think that marijuana industry actors like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) would wish that UK patients get as much access to Medical marijuana as those in Northern America.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Thursday, September 26th, 2019 Uncategorized Comments Off on $TGODF UK Experts Want Medical Marijuana Free for All

$PBIO Patented PCT Platform Highlighted in 10 Separate Presentations

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”) platform was prominently featured at the International Human Proteome Organization World Congress (“International HUPO”) in no less than ten separate presentations from scientists affiliated with seventeen leading research institutions worldwide. “We believe the unique value provided by our PCT platform for cancer research and diagnostics, which was broadly highlighted across ten presentations at this important international human protein conference, will help to accelerate awareness and adoption for our unique PCT sample preparation platform across multiple large and growing markets. Subsequently, we believe this increased awareness and conversion into adoption will result in increased sales of our PCT instruments and consumables in Q4 2019 and beyond,” Pressure BioSciences Global Director of Sales & Marketing Roxana McCloskey stated in the news release.

To view the full press release, visit http://nnw.fm/b8P6s

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, September 26th, 2019 Uncategorized Comments Off on $PBIO Patented PCT Platform Highlighted in 10 Separate Presentations

$OGI 3 Brand-Name Cannabis-Infused Beverage Stocks You Need to Know

Sep 26, 2019 at 6:06AM

The biggest marijuana day of the year is exactly three weeks away. On Oct. 17, 2019, marking the one-year anniversary since recreational marijuana sales commenced in Canada, rules governing the sale of derivative pot products will officially go into effect. However, new products won’t hit dispensary store shelves until about two months later.

Derivatives are non-dried-flower marijuana products. Examples include edibles, concentrates, vapes, topicals, and nonalcoholic infused beverages. Prior to Oct. 17, 2019, only dried cannabis flower, cannabis oil, and sublingual sprays were given the green light by regulatory agency Health Canada.

The excitement surrounding the launch of derivatives is easy to wrap your hands around as an investor or business operator in the cannabis space for one simple reason: the margins are juicier. In select recreationally legalized U.S. markets, the oversupply and eventual commoditization of dried flower has led to a steady decline in per-gram dried cannabis pricing, as well as margins. That oversupply concern simply doesn’t exist in the derivatives space.

Furthermore, derivatives tend to speak to a newer generation of marijuana-product consumers. With tobacco health concerns better known after decades of research, younger pot users prefer consumption options that don’t involve smoking dried flower. That’s where derivative pot products come into play.

Among the many alternative consumption options available, perhaps none has attracted more attention from brand-name cannabis stocks and ancillary players than infused beverages. Though there are no shortage of companies angling for their piece of the pie, the following three cannabis stocks are the ones you’ll want to know.

Canopy Growth

Canopy Growth (NYSE:CGC) is not only the largest marijuana stock in the world by market cap, but it’s liable to be one of the largest players in the infused beverage business. That distinction is the result of a massive equity investment from Corona and Modelo beer-maker Constellation Brands (NYSE:STZ) that closed in November.

The investment made by Constellation gave the company a 37% stake in Canopy Growth. Obviously, Constellation sees more in Canopy than just partnering up on a line of infused beverages; otherwise, it wouldn’t have taken a cumulative $4.2 billion equity stake and purchased approximately $150 million in convertible notes between Oct. 2017 and Nov. 2018. Nevertheless, Constellation Brands is looking for ways to naturally expand its reach into other vice industries, and cannabis is a natural evolution, according to its management team.

This partnership will allow Constellation and Canopy to bring their unique perspectives to the table in creating a line of infused cannabis beverages. Namely, Canopy will be leaned on for its expertise in cannabis, as well as its branding strengths and ability to land substantive supply deals. Meanwhile, Constellation Brands has a history of successful marketing, product innovation, and boasts deep pockets.

It’s unclear how much of a needle mover infused beverages will be for Constellation in the quarters to come, but it should be a difference maker for Canopy Growth.

OrganiGram Holdings

The thing about the cannabis industry is that businesses don’t need to be the size of Canopy Growth to be wildly successful at certain niches. New Brunswick-based OrganiGram Holdings (NASDAQ:OGI), which sports a roughly $650 million market cap, is a perfect example.

OrganiGram is focused on a slew of derivative options. It’s one of four suppliers chosen by PAX Labs for the Era vape device, and the company has spent 15 million Canadian dollars on a line of fully automated equipment that will allow for the production of 4 million kilos of infused chocolates each year. But the most intriguing aspect of OrganiGram’s derivatives line might just be its nano-emulsion technology that’s focused on beverages.

Earlier this year, OrganiGram announced that it had developed a nano-emulsification technology that can be added to beverages to speed up the process by which cannabinoids take effect. The company plans to introduce this technology first as a powder that users can add to an infused beverage of their choosing.

However, OrganiGram has also made clear that it would like to develop a line of infused cannabis beverages with this proprietary technology already built in. It’s been actively looking for a beverage partner to help develop and market a nano-emulsification beverage product, and I’d be genuinely surprised if it failed to find one relatively soon.

 

HEXO

A third brand-name Canadian pot stock that you’ll want to closely monitor as infused beverages begin to roll out is Quebec-based HEXO (NYSE:HEXO).

Even though Constellation’s $190 million equity investment into Canopy in Oct. 2017 marked the first foray of a major company into the cannabis space, it’s the joint venture between HEXO and Molson Coors Brewing (NYSE:TAP), announced on Aug. 1, 2018, that truly signaled a definitive focus on marijuana products between a brand-name company and a pot stock.

The joint venture, known as Truss, is majority-owned by Molson Coors (57.5% to 42.5%). As with the Constellation-Canopy equity investment, Molson and HEXO plan to lean on each other’s expertise to market their infused beverages. HEXO has keen knowledge of growing and processing marijuana, as well as landing major supply deals. Meanwhile, Molson Coors understands how to market beverage products and scale production.

Because Molson Coors is generating more than $10 billion annually in sales, it’s unclear how much of an impact infused beverages will have on its top or bottom line. But given its persistent decline in beer market share in Canada, partnering with a brand-name cannabis stock was a must for Molson Coors.

HEXO, on the other hand, should see an even more impactful increase on its sales from beverages than Canopy Growth. Look for 2020 to be a year of impressive sales and margin expansion for HEXO.

Thursday, September 26th, 2019 Uncategorized Comments Off on $OGI 3 Brand-Name Cannabis-Infused Beverage Stocks You Need to Know

$GNPX Featured in Audio Publication Discussing New Research on Breast Cancer Treatment

NEW YORK, Sept. 26, 2019 — via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers.”

To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/wd8LJ

To read the full editorial, visit: http://nnw.fm/n7Txk

Treatment for breast cancer varies, based on both the patient’s circumstances and type of cancer. The development of treatments to suppress or even eliminate cancer has led to a high survival rate in wealthy countries, with around 85% of patients in the United States and United Kingdom surviving for at least five years from diagnosis. But even in these countries, survival depends upon the exact form of the cancer, how far it has progressed and whether a treatment has been developed for that particular form. Cancer is a difficult disease to defeat, and survival can depend upon the ability of scientists to counter a specific genetic defect in a specific set of cells.

Because cancers are so varied and challenging to tackle, every individual win is worth celebrating. That’s why recent news relating to triple-negative breast cancer (TNBC) has brought excitement both for independent researchers and for Genprex Inc. (NASDAQ:GNPX), a clinical-stage, gene-therapy company whose tumor suppressor candidate 2 (TUSC2) was found to prevent tumor growth in TNBC.

About Genprex Inc.

Genprex Inc. is a clinical-stage, gene-therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell-signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. Visit the company’s web site at www.genprex.com or follow Genprex on Twitter at twitter.com/genprex, Facebook at facebook.com/genprexinc and LinkedIn at linkedin.com/company/genprex.

About NetworkNewsAudio

NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit: www.NetworkNewsAudio.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

Thursday, September 26th, 2019 Uncategorized Comments Off on $GNPX Featured in Audio Publication Discussing New Research on Breast Cancer Treatment

$YGYI Closes $8.3M Public Offering; Launches HEMP FX Brand in Japan

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, on Tuesday announced the closing of its underwritten public offering of 333,500 shares of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock, including 43,500 shares pursuant to the exercise of the over-allotment option by the underwriters. The shares were sold at a public offering price of $25.00 each, resulting in gross proceeds of $8,337,500, prior to withholding discount, commissions and estimated offering expenses. The Benchmark Company, LLC acted as sole book-running manager of the offering.

In addition, YGYI this morning announced the launch of Hemp FX in Japan. Hemp FX is a phytocannabinoid-rich hemp oil product line that includes three proprietary formulas featuring full-spectrum, organically grown hemp oil. Hemp FX Soothe, Hemp FX Capsules and Hemp FX Tincture have obtained the applicable approvals and are now available for purchase in Japan. “Hemp FX is an ideal representation of our plant-based approach to product development. These select products are being offered in this initial launch, and we expect the Hemp FX line will continue to grow, with more products becoming available for sale in Japan in the near future,” Youngevity CEO Steve Wallach stated in the news release. “This product launch has really been creating excitement in the Japanese market and we expect that it will provide significant growth within our distributor base in Japan.”

To view the full press releases, visit: http://nnw.fm/dm9XD and http://nnw.fm/rt50R

About Youngevity International Inc.

Youngevity International Inc. is a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise, a commercial hemp enterprise and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity; YGYI offers products from the six top-selling retail categories, including health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry and innovative services. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, September 25th, 2019 Uncategorized Comments Off on $YGYI Closes $8.3M Public Offering; Launches HEMP FX Brand in Japan

$TGODF Confirms Robust Demand for Premium Organic Cannabis

  • The Green Organic Dutchman produces high-quality, organic cannabis for the medicinal and recreational adult use markets from purpose-built, state-of-the-art facilities
  • The company has confirmed higher demand for premium organic cannabis
  • TGOD has also announced positive results from its pharmacokinetic study of innovative cannabinoid technology

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is an international, premium organic cannabis company based in Mississauga, Ontario. The company produces high-quality, organic medical and recreational adult use cannabis using organic craft growing principles. TGOD plans on commercializing organic cannabinoid dissolvables in Canada beginning in December 2019 under the TGOD-Infusers line of premium cannabis products, and results from a recent study have given support to that move. Additionally, TGOD was able to report strong demand for its premium organic cannabis following its Ontario launch and fast-tracked shipments.

Following its Ontario launch and fast-tracked shipments, TGOD reported that there is a strong demand for its premium organic…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF

 

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, September 25th, 2019 Uncategorized Comments Off on $TGODF Confirms Robust Demand for Premium Organic Cannabis

$SRAX to Present at the 5th Annual B. Riley Consumer & Media Conference

LOS ANGELES, Sept. 25, 2019 — SRAX, Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, is scheduled to present at the 5th Annual B. Riley Consumer & Media Conference on Thursday, October 3, 2019, at the Sofitel Hotel in New York City.

CEO Chris Miglino will participate in a fireside chat with analyst Mike Crawford on October 3rd at 1:00 p.m. ET and will host one-on-one meetings with investors throughout the day. To schedule a meeting please contact your B. Riley representative.

About SRAX
SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency, and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury, and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information on SRAX, visit www.srax.com

CONTACT: Kirsten Chapman /Mary Magnani, LHA Investor Relations, 415.433.3777, srax@lhai.com

Wednesday, September 25th, 2019 Uncategorized Comments Off on $SRAX to Present at the 5th Annual B. Riley Consumer & Media Conference

$PBIO Proprietary Technology Platform Identified as Key Cancer Biomarker Research Element

  • Independent research carried out by Chinese and Australian scientists shows that the Pressure BioSciences Pressure Cycling Technology (PCT) platform is excellent for the processing of preserved (formalin-fixed paraffin-embedded, or FFPE) and fresh frozen biopsy tissues, which are considered invaluable for discovering cancer biomarkers
  • Such tissues play a pivotal role in cancer research and may potentially contribute to the development of therapies and prevention protocols
  • Cancer research is one of the more rapidly growing sectors making use of PBIO’s technology; to prepare for further expansion in the future, the company has appointed a new, highly experienced chief financial officer
  • The company recently announced that Daniel J. Shea has joined the team as chief financial officer and senior vice president, in anticipation of growth

Pressure BioSciences Inc.’s (OTCQB: PBIO) novel and powerful Pressure Cycling Technology (PCT) platform has performed excellently during the processing of preserved (FFPE) and fresh frozen biopsy tissue samples for the discovery of cancer biomarkers, as indicated by two recently published scientific articles about the technology’s performance.

Independent teams of scientists from China and Australia led the research, and their data suggest that the Pressure BioSciences technology could potentially be used in the clinical diagnostic process based on the cancer biomarkers, as the company noted in…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

 

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, September 25th, 2019 Uncategorized Comments Off on $PBIO Proprietary Technology Platform Identified as Key Cancer Biomarker Research Element

$OGI One of the Largest Licensed Cannabis Producers in Canada

Organigram is one of the few companies to have distribution of their recreational cannabis in all 10 provinces

Organigram Holdings Inc. is the parent company of Organigram Inc., a leading Canadian licensed producer of premium quality cannabis and extract-based products.

Production Facility

“Where the majority of companies went with large green house expansions, our facility is three levels. We actually do vertical cultivation”, says CEO, Greg Engel.

Organigram’s production facility is located on a 14-acre campus in Moncton, New Brunswick. There, its Phase 4 fully-funded expansion project is underway to increase target production capacity to 113,000 kg/year. Not to mention, they expect construction is to be completed by the end of 2019.

Furthermore, the Phase 4 expansion includes a state-of-the-art mechanical system. Additionally, it has an improved irrigation system which they expect to be one of the most sophisticated in North America.

More on Organigram Holdings

Organigram began as a medical cannabis provider. Today, the company is focusing on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada. They’re also developing international business partnerships to extend the its global footprint.

“We’ve had four quarters in a row now, positive adjusted EBITDA. And I think that’s a big differentiator for us”, say Engel.

Organigram is focusing on translating operational excellence into strong financial results and return on investment for shareholders.

Wednesday, September 25th, 2019 Uncategorized Comments Off on $OGI One of the Largest Licensed Cannabis Producers in Canada

$LXRP Powdered Formulation of CBD-Rich Hemp Oil Now Available to US Consumers

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently launched its ChrgD+ product, a water-soluble, multispectrum hemp oil in a powdered format powered by the company’s proprietary DehydraTECH(TM) technology for rapid CBD delivery (http://nnw.fm/Ql3vI). An article discussing the company reads, “The rapid biodelivery of CBD through DehydraTECH provides an avenue for safer, less-conspicuous consumption of CBD than inhaling it through smoke or vapor during a critical time when social acceptance of cannabis products is exploding age-old prohibitions but many legislative entities continue to struggle with regulatory issues on behalf of the public welfare. . . . ChrgD+ has been available in a limited number of retail stores throughout the Western United States, but the announcement that it is now available via commercial web delivery to locations where it can be legally consumed means that anyone has the potential to obtain it through the website www.ChrgD.life  without having to travel. Limited-time promotional offers and product updates are also available through the site.”

To view the full article, visit: http://nnw.fm/c4BJW

About Lexaria Bioscience Corp.

Lexaria is a global innovator in drug-delivery platforms. Its patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption, reduces time of onset, and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and more than 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, September 25th, 2019 Uncategorized Comments Off on $LXRP Powdered Formulation of CBD-Rich Hemp Oil Now Available to US Consumers

$GGBXF to Report Results, Host Earnings Conference Call for Q4 and Fiscal Year 2019

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Tuesday announced that it will report results for the fourth quarter and fiscal year 2019 ending June 30, 2019, on Wednesday, October 23, 2019, at approximately 5:00 PM ET. In addition, Green Growth Brands will host a conference call with company management in conjunction with release of its financial results, with the call slated to take place on Thursday, October 24, 2019, at 8:30 AM ET. Interested parties may join the conference by dialing (+1) 416 764 8609 (Local Toronto), (+1) 778 383 7417 (Local Vancouver) or (+1) 888 390 0605 (North American Toll-Free) and entering Conference ID: 66844833. The call and archived replay will be accessible on Green Growth Brands’ Investor Relations website.

To view the full press release, visit: http://nnw.fm/1LloQ

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S. its CBD presence at ShopSeventhSense.com, in malls across the country, at DSW and Abercrombie & Fitch stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://nnw.fm/GGBXF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, September 25th, 2019 Uncategorized Comments Off on $GGBXF to Report Results, Host Earnings Conference Call for Q4 and Fiscal Year 2019